Renal Medullary Carcinoma Response to Chemotherapy: a Referral Center Experience in Brazil

Renal medullary carcinoma (RMC) is rare, accounting for less than 1% of all renal neoplasms. Case reports suggest RMC is highly aggressive, poorly responsive to chemotherapy, often metastatic at diagnosis, affects young men with sickle cell trait, and median overall survival (mOS) is less than 12 mo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Maroja Silvino, Marina Cavalcanti, Venchiarutti Moniz, Camila Motta, Munhoz Piotto, Gustavo Henrique, Siqueira, Sheila, Galapo Kann, Ariel, Dzik, Carlos
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: PAGEPress Publications, Pavia, Italy 2013
Konular:
Case Report
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3804819/
https://ncbi.nlm.nih.gov/pubmed/24179656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4081/rt.2013.e44
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller